Pinnacle Wealth Planning Services’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$939 Sell
62
-71
-53% -$1.07K ﹤0.01% 2590
2026
Q1
$1.45K Hold
133
﹤0.01% 2500
2025
Q4
$1.72K Buy
+133
New +$1.71K ﹤0.01% 2510
2021
Q1
Sell
-173
Closed -$30K 1413
2020
Q4
$30K Buy
+173
New +$23.7K 0.01% 1001

Other funds holding NVCR

Pinnacle Wealth Planning Services's NVCR Position: Q2 2026 in Review

Pinnacle Wealth Planning Services reduced its NovoCure (NVCR) stake by 53% in Q2 2026, selling an estimated $1.07K and leaving 62 shares worth $939. The position accounts for ﹤0.01% of the portfolio, ranked #2590.

Pinnacle Wealth Planning Services first reported a position in NVCR in Q4 2020 and has held it in 4 quarters since. The position peaked at $30K in Q4 2020. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Pinnacle Wealth Planning Services held 62 shares of NovoCure worth $939 as of Q2 2026.
  • Pinnacle Wealth Planning Services sold 71 NovoCure shares in Q2 2026, an estimated $1.07K.
  • NovoCure made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #2590 holding.
  • Pinnacle Wealth Planning Services first reported a position in NovoCure in Q4 2020 and has held it in 4 quarters since.
  • Pinnacle Wealth Planning Services's NovoCure position peaked at $30K in Q4 2020.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.